Ludwig Enterprise mRNA Program Generating Broad Clinical Interest
SPARKS, NV / ACCESSWIRE / March 14, 2023 / Ludwig Enterprises, Inc. (Ludwig - The Genomics Language Company™) and its subsidiary Precision Genomics has attracted significant clinical interest in its patent pending mRNA Inflammatory Index™ which …
Weiterlesen »